Skip to content

In vitro maturation of human oocytes with subsequent IVF or ICSI . An observational study with follow up of the children.

In vitro maturation of human oocytes with subsequent IVF or ICSI . An observational study with follow up of the children. - In vitro maturation

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31686
Enrollment
400
Registered
2008-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome reduced fertility

Interventions

None listed

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: PCOS or patients with a previous occurence of OHSS (ovarian hyperstimulation syndrome)

Exclusion criteria

Exclusion criteria: older than 38 years of age, early-follicular serum FSH over 10 IU/ml

Design outcomes

Primary

MeasureTime frame
* Nr, development and quality of embryos on day 3.

Secondary

MeasureTime frame
IVM treatment: * Nr of oocytes on day 0, after ovum pick-up. * Nr in vitro matured (MII) oocytes on day 1 (only visible with ICSI). * Nr of fertilised oocytes, pronucleï score. * Nr, development and quality of transfered embryos and cryopreserved embryos. pregnancy: * Result pregnancytest about 2 weeks after ovum pick-up. * Heartbeat by ultrasound, 6-8 weeks after ovum pick-up. * Follow up pregnancy partus: * Amenorrhoe * partus (spontaneous, sectio, forceps, vacuum) * Complications children: * Standard screening direclty after birth according to the Landelijke Verloskundige Registratie (LVR) * Follow up of children will be performed on several domains according to national and international standards. Shortly after birth, at 6 months, 1-, 2- and 5-years of age mental and motoric development will be scored according to national and international standards.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)